Press Releases

 
Press Releases
  Date Title View
Oct 5, 2006
Lyon, France, October 5, 2006 - EDAP TMS S.A. (NASDAQ: EDAP), the global leader in High Intensity Focused Ultrasound (HIFU) treatment of prostate cancer, announced it has signed a revenue per procedure (RPP) services contract to provide Ablatherm-HIFU treatment of localized prostate cancer at Helios Klinikum Wupper...
Sep 28, 2006
DURHAM, N.C. -- Duke University Medical Center is one of 12 centers in the country testing the safety and effectiveness of a minimally invasive procedure called High Intensity Focused Ultrasound (HIFU). Since 79-year-old Herbert Halbrecht's cancer was at an early stage and his prostate was small to moderate size, he qualified for HIFU no...
Sep 6, 2006
EDAP TMS S.A. (Nasdaq: EDAP), the global leader in High Intensity Focused Ultrasound (HIFU) treatment of prostate cancer, presented at the Roth Capital Partners New York Conference on September 6, 2006 at the Westin Time Square Hotel in New York, NY. ...
Aug 24, 2006
Lyon, France, August 24, 2006 - EDAP TMS S.A. (Nasdaq: EDAP), the global leader in High Intensity Focused Ultrasound (HIFU) treatment of prostate cancer, announced management will present at the Roth Capital Partners New York Conference on September 6, 2006 at the Westin Time Square Hotel in New York, NY. The compa...
Aug 8, 2006
Lyon, France, August 8, 2006 – EDAP TMS S.A. (Nasdaq: EDAP), today reported results for the second quarter and first half ended June 30, 2006. Growth in the company's HIFU revenue per procedure (RPP) business continues strongly as the company executes its strategy to roll out additional marketing and sales programs to accelerate growth...
Aug 3, 2006
Lyon, France, August 3, 2006 - EDAP TMS S.A. (Nasdaq: EDAP), will release its second quarter financial results for the period ending June 30, 2006 on Tuesday, August 8, 2006 after the market close. Management will host a conference call to discuss the results and answer questions from investors on Wednesday, August 9, 2006, a...
Aug 3, 2006
Lyon, France, August 3, 2006 - EDAP TMS S.A. (Nasdaq: EDAP) the global leader in High Intensity Focused Ultrasound (HIFU) treatment of prostate cancer announced the closing of its private placement of 961,676 ordinary shares in the form of American Depositary Shares, resulting in net proceeds of approximately $6.5 million. These funds are in...
Aug 1, 2006
Lyon, France, August 1, 2006 - EDAP TMS S.A. (Nasdaq: EDAP) the global leader in High Intensity Focused Ultrasound treatment of prostate cancer will be placing a third mobilized Ablatherm-HIFU device early September to serve the growing needs of the German market under its innovative revenue-per-procedure model. Ablatherm-HIFU is recognized ...
Jul 31, 2006
Lyon, France, July 31, 2006 - EDAP TMS S.A. (Nasdaq: EDAP) the global leader in High Intensity Focused Ultrasound treatment of prostate cancer announces the launch of Ablatherm-HIFU services at Hospital Privado da Boavista, Porto, Portugal, the first HIFU treatment center in Portugal. Boavista Hospital will be using the Ablatherm-HIFU device...
Jul 27, 2006
EDAP's Ablatherm-HIFU FDA clinical study was recently featured in the Triangle Business Journal. The article is viewable online at http://triangle.bizjournals.com/triangle/stories/2006/07/17/focus4.html . A patient treated ...
FirstPrevious ...
37
NextLast
= add release to Briefcase